Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trail is to compare the difference between transradial access (TRA) and transfemoral access(TFA) for ruptured intracranial aneurysms embolization. The main question it aims to answer is: whether is TRA not inferior to TFA? In the experimental group, the transradial access (TRA) was used, which was to puncture the radial artery and insert a radial sheath to establish a surgical pathway for embolization of the aneurysm; In the control group, transfemoral access (TFA) was used to embolize the aneurysms, which was to puncture the femoral artery and insert the femoral sheath to establish a surgical pathway for embolizing the aneurysms.The two groups of patients received an oral loading dose of aspirin (300mg) plus clopidogrel (300mg) on the day of surgery, while patients who were unable to take orally were given nasal feeding. During the operation, systemic heparinization was performed with a starting dose of 75U/kg intravenous injection, and the injection was halved every 1h until 1000U. After the operation, protamine neutralizing heparin (1mg protamine neutralizing 100U heparin) was used.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05851274
Study type Interventional
Source The First Affiliated Hospital with Nanjing Medical University
Contact Lei M Mao Lei
Phone 13057658078
Email 2165451550@qq.com
Status Not yet recruiting
Phase N/A
Start date May 10, 2023
Completion date May 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT04801901 - Distal Transradial Access for Percutaneous Coronary Intervention N/A